Takeda Pharmaceutical Co (MEX:TAK) Accounts Payable : MXN56,932 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Accounts Payable?

Takeda Pharmaceutical Co's Accounts Payable for the quarter that ended in Sep. 2024 was MXN56,932 Mil.

Takeda Pharmaceutical Co's quarterly Accounts Payable increased from Mar. 2024 (MXN35,443 Mil) to Jun. 2024 (MXN54,415 Mil) and increased from Jun. 2024 (MXN54,415 Mil) to Sep. 2024 (MXN56,932 Mil).

Takeda Pharmaceutical Co's annual Accounts Payable declined from Mar. 2022 (MXN49,692 Mil) to Mar. 2023 (MXN41,461 Mil) and declined from Mar. 2023 (MXN41,461 Mil) to Mar. 2024 (MXN35,443 Mil).

Takeda Pharmaceutical Co Accounts Payable Historical Data

The historical data trend for Takeda Pharmaceutical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Accounts Payable Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable

Get a 7-Day Free Trial

46,088.55

43,647.63

49,691.95

41,460.89

35,443.23

Takeda Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															49,610.84	57,020.29	35,443.23	54,415.09	56,932.23

Takeda Pharmaceutical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Takeda Pharmaceutical Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan 0A87:UK TKDA:Germany TAKP34:Brazil TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.